Back to Search
ROBERT RUXER, MD
MD
Medical Oncology Physician
NPI: 1649217647Individual
Specialties, Licenses & Credentials
Research & Publications (5)
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
PMID 19036692·Clin Colorectal Cancer·2008
3-trial
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
PMID 18978567·J Thorac Oncol·2008
3-trial
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium.
PMID 18236006·Invest New Drugs·2008
3-trial
Phase I trial of topotecan in combination with gemcitabine in refractory solid tumor patients.
PMID 15493356·Cancer Invest·2004
3-trial
Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.
PMID 11822760·Ann Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 S HENDERSON ST STE 200
FORT WORTH, TX 76104 - Phone
- (817) 413-1500
Quick Facts
- NPI
- 1649217647
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile